Similarly, in hepatic cancer animal models treated with MitoQ [45], and in liver cancer, Cx32 has been shown to negatively regulate the expansion of liver cancer stem cells and, as expected, was positively correlated with patient survival [46]. The gene discussed is GJB1; the disease is liver cancer.